BNP Paribas Bonus Zert HNR1 27.06.../ DE000PC2Y790 /
02/05/2024 21:40:14 | Diferencia+0.090 | Bid21:54:49 | Ask02/05/2024 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
218.180EUR | +0.04% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
HANNOVER RUECK SE NA... | - - | 27/06/2024 | Call |
GlobeNewswire
14:05
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
14:00
Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
GlobeNewswire
14:00
Franklin Electric Appoints Joe Ruzynski as CEO; Gregg Sengstack Remains Executive Chairperson
GlobeNewswire
14:00
Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules
GlobeNewswire
14:00
Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial...
GlobeNewswire
14:00
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
14:00
Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update
GlobeNewswire
14:00
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
14:00
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire
14:00
Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
14:00
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
GlobeNewswire
14:00
Verifone and Logos in Strategic Partnership to Revolutionize Unattended Payments
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página